amyris inc amrso company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile amyris inc amrso related topics stocksstock screenerbasic materialsspecialty chemicals overview news key developments people charts financials analysts research pulse amrso on nasdaq usd am edt change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description amyris inc incorporated on april   is an integrated industrial biotechnology company the company is engaged in research and development and sales of fuels and farnesenederived products the company is applying its industrial synthetic biology platform to engineer manufacture and sell products into a range of consumer and industrial markets including cosmetics flavors and fragrances ff solvents and cleaners polymers lubricants healthcare products and fuels the company intends to apply its technology to the development of pharmaceutical products the company focuses on a renewable hydrocarbon molecule called farnesene biofene which forms the basis for a range of products including emollients flavors and fragrance oils and diesel fuel the companys subsidiaries are amyris brasil ltda and amyris fuels llcthe company is producing approximately four molecules at its industrial fermentation plant artemisinic acid farnesene and over two fragrance molecules the company is expanding its range of products across various categories divided into consumer and industrial applications for consumer applications the company is developing and selling personal care products which include ingredients for cosmetics and ff healthcare products and formulated end user products such as biossance brand skincare products and muck daddy brand hand cleaner product it is pursuing arrangements with a number of drug companies for their use of its molecules to develop pharmaceutical products for industrial applications the companys products include performance materials such as solvents and polymers and with its joint venture partners renewable lubricants and fuels its initial portfolio of commercial products has been based on biofene and biofene derivatives in addition it has produced at scale and commercialized over two target molecules for the ff market the company markets its solvent product under the myralene brand the company is developing applications for its farnesene that include highperformance polymers used in tires and other applications using farnesene the company produces renewable diesel a farnesene derivative referred to as farnesane and jet fuel » full overview of amrso company address amyris inc  hollis st ste emeryville   ca    p f  company web links home page officers  directors name compensation john melo  kathleen valiasek  joel cherry  karen rohde  chris jaenike  » more officers  directors amyris inc news briefamyris enters into first product development production agreement with royal dsm jul   briefamyris on june   company issued sold an amended restated note in principal amount of  mln to purchaser jul   briefamyris and government of queensland announced plans to develop a industrial biotechnology hub in southeast asia jun   briefamyris announces reverse stock split jun   briefamyris reports q loss per share of  may   » more amrso news related topics stocksstock screenerbasic materialsspecialty chemicals amyris company  wikipedia amyris company from wikipedia the free encyclopedia jump to navigation search this article needs additional citations for verification please help improve this article by adding citations to reliable sources unsourced material may be challenged and removed november  learn how and when to remove this template message amyris inc type public nasdaq amrs industry renewable fuels antimalaria renewable chemicals renewable products founded  headquarters emeryville california usa key people john melo ceo revenue none number of employees    website amyriscom amyris is an integrated renewable products company providing sustainable alternatives to a broad range of petroleumsourced products and rare materials amyris in conjunction with various partners is creating industrial scale supplies of vitamins captive perfume molecules like ambroxan a patchouli substitute and farnesene which can be used in tires and lubricant as well as their own beauty care product line using squalane their substitute molecule for shark oil amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules flexible building blocks which can be used in a wide range of products they do this by reengineering yeast so it can recreate complicated molecules the time to market was reduced four fold after amyris teamed with darpa amyris is commercializing these products both as renewable ingredients in cosmetics flavors fragrances polymers lubricants and consumer products and also as renewable diesel and jet fuels amyris brasil sa a subsidiary of amyris oversees the establishment and expansion of amyris’s production in brazil amyris also has fuel distribution capabilities in the united states through its subsidiary amyris fuels llc founded in  and headquartered in emeryville ca amyris has raised over  million in equity funding todate including investments from royal dsm total sa khosla ventures votorantim novos negócios kleiner perkins caufield  byers tpg biotech and dag ventures as well as darpa amyris is opening two more plants in new zealand and korea in proximity to sustainable sugar cane crops the company went public on nasdaq in october  amrs but as of january  was trading at less than  of its initial offering price due to lack of commercial success in costeffectively producing drop in synthetic transportation fuel which was to be its initial major focus the firm has now focused its attention on higherpriced and highermargin products that are not in the transportation fuel area  contents  renewable fuels  artemisinin  media coverage  references  external links renewable fuelsedit amyris technology platform branded no compromise is focused on providing high performance petroleumalternatives using sustainable feedstock such as sugarcane amyris is establishing the partnerships and capabilities needed to bring the renewable diesel fuel to market a few of these actions include distributing ethanol through a us subsidiary amyris fuels based in chicago il building a large scale production facility at sao martino one of brazils largest ethanol producers joint venture with cosan one of brazils largest ethanol distributors and marketers artemisininedit artemisinin is a compound naturally found in the chinese sweet wormwood plant effective in the treatment of malaria its production is hampered by difficult climate and agricultural conditions institute for oneworld health received a grant from the bill and melinda gates foundation to develop and produce nonseasonal highquality affordable artemisinin and engaged amyris biotechnologies and sanofi to assist on certain parts of the project which is near completion based on technology from uc berkeley nrc canada and other sources media coverageedit using microbes to create the next generation of fuels on cnn the next list february  a better biofuel on mit technology review april  bets on biotech on us news november  referencesedit  fast company magazine  august  the rise and fall of the company that was going to have us all using biofuels external linksedit official website retrieved from httpsenwikipediaorgwindexphptitleamyriscompanyoldid categories companies based in emeryville californiabiotechnology companies of the united statesbiotechnology companies established in companies listed on nasdaq establishments in californiaamerican companies established in hidden categories articles needing additional references from november all articles needing additional referencespages using deprecated image syntax navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view amrs  summary for amyris inc  yahoo financehomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoreyahoosearchsearchus markets close in  hrs  minssp  dow  nasdaq amyris inc amrsnasdaqgs  nasdaqgs real time price currency in usdadd to watchlist as of am edt market openpeople also watchgevocdxsxgtiptximnpsummaryconversationsstatisticsprofilefinancialsoptionsholdershistorical dataanalystsddmmytdyymaxfull screenprevious closeopenbid x ask x days range   week range  volumeavg volumemarket capmbetape ratio ttmeps ttmearnings dateaug    aug  dividend  yieldna naexdividend datenay target esttrade prices are not sourced from all marketsallnewspress releasesglobenewswire• hours agoamyris to announce second quarter  financial results on thursday august  emeryville calif aug   amyris inc will report financial results for the second quarter ended june   after market close on thursday august   the company will hold its quarterly sponsoredbinaryunohow to get paid  everyday without a jobbetter than your job  this copy  paste method makes more moneyglobenewswire• days agoamyris biossance launches in sephora canada storesemeryville calif july   biossance™ the consumer beauty brand from amyris inc today announced that it will expand to sephora in over  sephora locations across canada in january  marking yahoo small businessdata disclaimerhelpsuggestionsprivacyabout our adsterms updated amyris inc    facebook facebook？關於相片評論影片貼文社群建立粉絲專頁登入 facebook  amyris inc ，。 facebook  amyris inc ，。      hollis st wwwamyriscom ·   berkeley biolabsbiocuriousbiobuilderbiotechnology （位於）地標amyris inc · english us · español · português brasil · français france ·  ·  · ad choices · cookie ·  facebook   ben yuan · as per previous employees poor management just painting good pictures getting paid a lot for burning money fast totally destroyed the company lost  of the value plus massive debt the revenue is even not enough pay for directorss salaryoluwarantimifunrere akindeleakinniyi · amyris is an innovative company with great result in anything it doesthis is an amazing establishment that raise hopebdoe future technology and human and environment safetysteve salter · sounds like farnesene is a strong canidate to change everythinghyeok hahntrue hydrocarbon biofuels nobody can match that haamyris darpa living foundries projectamyris inc ·   · amyris to announce second quarter  financial results on thursday august   httpbitlyvpxlamyris to announce second quarter  financial results on thursday august  emeryville calif aug   globe newswire  amyris inc nasdaqamrs will report financial results for the second quarter ended june   after market close on thursday august   the company winvestorsamyriscomamyris inc ·   · amyris biossance launches in sephora canada stores httpbitlyvfyamyris biossance launches in sephora canada storesemeryville calif july   globe newswire  biossance™ the consumer beauty brand from amyris inc nasdaqamrs today announced that it will expand to sephora in over  sephora locations across canada in january investorsamyriscomamyris inc ·   · amyris enters into first product development and production agreement with royal dsm for food and nutrition molecule httpbitlyubwqamyris enters into first product development and production agreement with royal dsm for food and nutrition moleculeemeryville calif july   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announces that it has entered into its first product development and production agreement with koninklijke dsminvestorsamyriscomamyris inc ·  · amyris announces reverse stock split  delivering on strong product revenue growth and execution httpbitlyrnkitamyris announces reverse stock split  delivering on strong product revenue growth and executionemeryville calif june   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced that it will effect a reverse stock split previously approved by the companys stockholders at its ainvestorsamyriscomamyris inc ·  · amyris exceeds previous debt reduction goal of  million —  million in debt retired httpbitlyqhmyuamyris exceeds previous debt reduction goal of  million —  million in debt retiredemeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced it has already exceeded the debt reduction goal the company stated in its may   announcements rinvestorsamyriscomamyris inc ·  · amyris announces closing of first tranche of up to  million in equity financing conversion of debt to equity httpbitlyqbadamyris announces closing of first tranche of up to  million in equity financing and conversion of over  million of debt to equityemeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced the closing of the first tranche of up to  million in planned equity financing that the company prinvestorsamyriscomamyris inc ·  · amyris ontrack to double revenue for vitamin e partnership with nenter exclusive vitamin a license with dsm httpbitlyqgcqmamyris ontrack to double revenue for vitamin e partnership with nenter  announces exclusive vitamin a license with royal dsmemeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced that it expects revenue related to its vitamin e partnership with nenter to more than double based investorsamyriscomamyris inc ·  · amyris announces agreements for up to  million in equity financing inprocess initiative to reduce debt httpbitlyptjukfamyris announces agreements for up to  million in equity financing and inprocess initiative to significantly reduce debtemeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced a series of agreements for up to  million in equity financing via a registered direct offering of investorsamyriscomamyris inc ·  · royal dsm to make equity investment in amyris with the purpose of establishing a longterm relationship httpbitlyqgyoybroyal dsm to make equity investment in amyris with the purpose of establishing a longterm relationshipheerlen netherlands and emeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company and koninklijke dsm nv royal dsm aexdsmas the global sciinvestorsamyriscomamyris inc ·  · amyris announces much better than expected sales of farnesene to meet accelerated demand by global tire brands httpbitlyqcczzamyris announces much better than expected sales of farnesene to meet accelerated demand for liquid farnesene rubber by global tire brandsemeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced that its partners success in developing high performance liquid farnesene rubber lfr for use in wiinvestorsamyriscomamyris inc ·  · amyris announces key advancements under darpa multiyear technology investment agreement httpbitlyputhfamyris announces key advancements under darpa multiyear technology investment agreement — enables development of industrialscale fermentation process for virtually any biological moleculeemeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced that it has successfully expanded its worldclass expertise in strain engineering and optimization investorsamyriscomamyris inc ·  · amyris announces industrial production of leading healthy sweetener product in  httpbitlyqortohamyris announces industrial production of leading healthy sweetener product in emeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced that it has made significant progress in the development of its healthy sweetener product technology investorsamyriscomamyris inc ·  · amyris agrees to exclusive china manufacturing with blue california httpbitlyorkqavamyris agrees to exclusive china manufacturing with blue california enabling continued record product revenue growth into asian marketsemeryville calif april   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced that it has expanded the scope of its relationship with phyto tech corp dbainvestorsamyriscomamyris inc ·  · amyriss biossance delivers record firstquarter sales —  eye product at sephora httpbitlyoapkamyriss biossance delivers record firstquarter sales —  eye product at sephora and on track for much better than expected emeryville calif april   globe newswire  amyris inc nasdaqamrs the industrial bioscience company achieved record firstquarter product sales for its biossance brand which is delivering highgrowth and is expecteinvestorsamyriscomamyris inc ·  · biossance squalane  probiotic gel moisturizer is  on w magazines  best new moisturizers httpbitlyprbzuthe  best new moisturizers to try this springfrom vitaminc packed gels to japanese wild rose water creams here a closer look at the  new best moisturizers to try this springwmagazinecom查看 amyris inc enters into first product development and production agreement with royal dsm for food and nutrition molecule employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       amyris inc enters into first product development and production agreement with royal dsm for food and nutrition molecule tweet   am   life sciences jobs     bullet newest jobs  last  hours   bullet california jobs   bullet massachusetts jobs   bullet new jersey jobs   bullet maryland jobs   bullet washington jobs   view more jobs emeryville calif july   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announces that it has entered into its first product development and production agreement with koninklijke dsm nv royal dsm aexdsmas the global sciencebased company active in health nutrition and materials to develop a food and nutrition molecule for which dsm is a major market provider as part of the previously announced equity investment dsm is making into amyris dsm and amyris have agreed to focus on a number of short to mediumterm product development  production opportunities in vitamins and other nutritional ingredients this agreement is the first of what is expected to be several of such development and production projects as part of the agreement dsm will partner with amyris and fund the development of the technology to produce the specific molecule that amyris will scale and supply long term to deliver improved performance while growing its business dsm will take the molecule to market utilizing its channel and market access and take advantage of amyris’s biotechnology production which provides a lower cost of production than currently available we are very excited to partner with dsm on our first product development and production agreement said john melo amyris president  ceo this is the first of what are expected to be several highly disruptive products addressing major markets where together we can leverage amyris’s technology platform to reduce cost for products dsm then takes to market in a costadvantaged position about amyris amyris is the integrated renewable products company that is enabling the worlds leading brands to achieve sustainable growth amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products the company is delivering its no compromise® products across a number of markets including specialty and performance chemicals flavors and fragrances cosmetics ingredients pharmaceuticals and nutraceuticals more information about the company is available at wwwamyriscom forwardlooking statements this release contains forwardlooking statements regarding amyris and any statements regarding amyris other than statements of historical facts could be deemed to be forwardlooking statements these forwardlooking statements include among other things statements regarding future events such as expected future development and production projects between amyris and dsm amyris’s anticipated cost of production for the molecule subject to the current development and production agreement with dsm and amyris’s expected future performance and business growth that involve risks and uncertainties these statements are based on managements current expectations and actual results and future events may differ materially due to risks and uncertainties including risks related to manufacturing capacity at amyriss brotas facility delays or failures in development production and commercialization of products liquidity and ability to fund capital expenditures amyriss reliance on third parties to achieve its goals and other risks detailed in the risk factors section of amyriss quarterly report on form q filed on may   amyris disclaims any obligation to update information contained in these forwardlooking statements whether as a result of new information future events or otherwise amyris the amyris logo and no compromise are registered trademarks of amyris inc all other trademarks are trademarks of their respective owners contact peter denardo director investor relations and corporate communications amyris inc    investoramyriscom pramyriscom read at biospacecom related news gen and amyris inc announce supply agreement for synthetic dna bay areas oncomed omed tanks some more as glaxosmithkline gsk walks away from rd pact amyris inc creates program to reduce the cost and increase access to leading malaria treatment biotech bestie celgene celg takes stake inks  billion deal with beigene bgne amyris inc announces offering of  million of convertible senior notes due  how transformative is this licensing deal for beigene bgne royal dsm invites entrepreneurs to participate in a unique innovation  partnering conference the  biotechs that could make celgene celg even richer royal dsm publishes  integrated annual report biospace dhx partners with bio business solutions to offer cost savings to bio members please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • amyris inc • royal dsm   • biotechpharma  alliances                 amyris inc amrso key developments  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states amyris inc amrso related topics stocksstock screenermarket databasic materialsspecialty chemicals overview news key developments people charts financials analysts research pulse amrso on nasdaq usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  latest key developments source significant developments amyris says collaboration with pharmaceutical company for biosynthetic drug discovery friday  oct  pm edt  amyris inc amyris inc collaboration with pharmaceutical company for biosynthetic drug discovery  full article amyris agrees to collaborate with leading global food ingredients and nutraceuticals partner thursday  oct  am edt  amyris inc  amyris agrees to collaboration terms with leading global food ingredients and nutraceuticals partner  amyris inc  expects to receive cash representing a shortterm collaboration investment of  million amyris inc  expects to receive an equity investment of up to  million at  per share  million in annual revenue starting in   full article amyris expanded its strategic partnership with a global nutraceuticals market leader friday  sep  am edt  amyris inc  expanded its strategic partnership with a global nutraceuticals market leader  new agreement includes addition of a new nutraceutical target a credit line of up to  million with a year maturity  says anticipated revenues from expanded partnership are expected to average over  million annually beyond  new agreement includes an option for a million strategic investment  full article amyris q adjusted loss per share  thursday  aug  pm edt  amyris inc  q loss per share   q  gaap revenues of  million nongaap revenues of  million  amyris reports second quarter  results q adjusted loss per share  excluding items  full article amyris enters partnership with biogen wednesday  aug  am edt  amyris inc  collaboration will explore use of amyriss microbe engineering technology amyris enters partnership with biogen to develop alternative cell lines supporting production of therapeutics  full article american refining group invests in novvi to accelerate amyris commercialization of renewable base oil and lubricant platform tuesday  jul  am edt  amyris inc  american refining group invests in novvi to accelerate amyris commercialization of renewable base oil and lubricant platform committed to  equity investment into jv amyris  cosan to continue to hold share ownership stakes in novvi with arg  full article amyris entered into note purchase agreement with foris ventures llc wednesday  jun  pm edt  amyris inc  on june   entered into note purchase agreement with foris ventures llc for sale of  million in aggregate principal amount of secured promissory notes interest will accrue on notes from  including june   at a rate of  per annum and is payable in full on may   sec filing  full article amyris inc enters into strategic partnership agreement with ginkgo bioworks wednesday  jun  am edt   amyris inc says on june   co entered into a strategic partnership agreement with ginkgo bioworks inc  amyris inc says co will transfer certain intellectual property to ginkgo by june   in exchange for a fee of  million to be paid by ginkgo  amyris inc says co would issue to ginkgo an option to purchase  million shares of common stock of company at an exercise price of  source  httpusagovnhm bengaluru newsroom      full article ginkgo bioworks says partners with amyris inc wednesday  jun  am edt  ginkgo bioworks   co amyris announced partnership which will enable companies to jointly develop products partnership is expected to generate over  million in incremental value for both companies over next  years  full article amyris announces long term collaboration with givaudan tuesday  jun  pm edt  amyris announces long term multimilliondollar collaboration in cosmetic active ingredients with givaudan  full article previous next amyris inc news briefamyris enters into first product development production agreement with royal dsm  amyris enters into first product development and production agreement with royal dsm for food and nutrition molecule » more amrso news earnings vs estimates » more financials related topics stocksstock screenermarket databasic materialsspecialty chemicals amyris inc nasdaqamrs quotes  news  google financemy accountsearchmapsyoutubeplaygmaildrivecalendargoogletranslatephotosmoredocsbloggercontactshangoutskeepeven more from googlesign inhidden fieldssearch financeadobe flash player is required for interactive charts allowfinanceamyris incnasdaqamrsadd to portfoliocompanysummarynewsrelated companieshistorical pricesfinancialsmarketsnewsportfoliosstock screenergoogle domestic trendsrecent quotes  daysyou have no recent quoteschg   amyris inc  public nasdaqamrs   watch this stock      realtime   am edt nasdaq realtime data  disclaimer currency in usd range     week    open  vol  avg  mkt cap m pe      divyield      eps  shares m beta  inst own  news relevance date all news for amyris inc » subscribe advertisement events add amrs to my calendars aug   q  amyris inc earnings release estimated  pm edt  jul   amyris inc extraordinary shareholders meeting may   amyris inc at cowen technology media  telecom conference may   amyris inc annual shareholders meeting may   amyris inc corporate analyst meeting  may   q  amyris inc earnings call  may   q  amyris inc earnings release more events from dailyfinance »     key stats and ratios q mar   net profit margin   operating margin   ebitd margin   return on average assets   return on average equity   employees   cdp score   address  hollis st ste emeryville ca united states  map phone fax website links httpsamyriscom external links analyst estimates  marketwatch sec filings  edgar online major holders  msn money research reports  reuters settings  technicals  link to this view volume delayed by  minsprices are not from all markets sources include six advertisement related companies show most recent quarter most recent annual add or remove columns save changes cancel sector basic materials  industry industrial biotechnology chemicals more from factset » description amyris inc is an integrated industrial biotechnology company the company is engaged in research and development and sales of fuels and farnesenederived products it is applying its industrial synthetic biology platform to engineer manufacture and sell products into a range of consumer and industrial markets including cosmetics flavors and fragrances ff solvents and cleaners polymers lubricants healthcare products and fuels the company focuses on a renewable hydrocarbon molecule called farnesene biofene the company is expanding its range of products across various categories divided into consumer and industrial applications for consumer applications the company is developing and selling personal care products which include ingredients for cosmetics and ff healthcare products and formulated end user products such as biossance brand skincare products and muck daddy brand hand cleaner product more from reuters » officers and directors john g melo president chief executive officer director age  bio  compensation   reuters kathleen valiasek chief financial officer bio  compensation   reuters joel cherry phd president  research and development age  bio  compensation   reuters karen d rohde chief human resources officer bio  compensation   reuters chris jaenike interim general counsel bio  compensation   reuters philip eykerman director age  bio  compensation   reuters abraham klaeijsen director bio  compensation   reuters christophe vuillez director bio  compensation   reuters patrick y yang director age  bio  compensation   reuters abdullah bin khalifa al thani independent director age  bio  compensation   reuters full list on reuters » google finance beta available in hong kong  canada  us  china  ukinformation is provided as is and solely for informational purposes not for trading purposes or advice and may be delayedto see all exchange delays please see disclaimer google  google home  blog  help  report a problem  privacy policy  terms of service amrsnasdaq gs stock quote  amyris inc  bloomberg markets error could not add to watchlist x  watchlist amyris inc amrsus nasdaq gs usd   as of  am edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector energy  price change  industry energy  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later  hours ago amyris to announce second quarter  financial results on thursday august    amyris biossance launches in sephora canada stores  synthetic biology market size is projected to be around  billion by  crystal market research  acelrx pharmaceuticals appoints raffi asadorian as chief financial officer  amyris enters into first product development and production agreement with royal dsm for food and nutrition molecule  robbins arroyo llp is investigating the officers and directors of amyris inc amrs on behalf of shareholders  amyris partners with queensland on biofutures acceleration program in next step toward planned development of biorefinery  deadline today levi  korsinsky llp reminds shareholders of amyris inc of a class action lawsuit and a lead plaintiff deadl  june  deadline khang  khang llp announces a securities class action lawsuit against amyris inc and reminds investors with  monday deadline lundin law pc announces a securities class action lawsuit against amyris inc and reminds investors with loss there are currently no press releases for this ticker please check back later profile amyris inc is a renewable products company the company provides alternatives to select petroleumsourced products used in specialty chemical and transportation fuel markets worldwide amyris is developing brazilian sugarcane as its primary feedstock address  hollis street suite emeryville ca united states phone  website wwwamyriscom executives board members john g melo presidentceo kathleen valiasek chief financial officer joel cherry presidentresearch  dev cynthia bryant cindy senior vpcorporate dev  collaborations peter denardo directorinvestor relations show more